Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 -27.56M
March 31, 2026 -26.34M
December 31, 2025 -29.08M
September 30, 2025 -25.99M
June 30, 2025 -17.10M
March 31, 2025 -21.86M
December 31, 2024 -16.99M
September 30, 2024 -20.78M
June 30, 2024 -17.18M
March 31, 2024 -17.86M
December 31, 2023 -14.94M
September 30, 2023 -10.67M
June 30, 2023 -19.49M
Date Value
March 31, 2023 -20.40M
December 31, 2022 -19.13M
September 30, 2022 -23.91M
June 30, 2022 -26.47M
March 31, 2022 -28.01M
December 31, 2021 -25.40M
September 30, 2021 -27.37M
June 30, 2021 -32.23M
March 31, 2021 -13.65M
December 31, 2020 -3.441M
September 30, 2020 -3.443M
June 30, 2020 -3.649M
March 31, 2020 -2.618M

Free Cash Flow Definition

Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

View Free Cash Flow (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow (Quarterly) Benchmarks

View Free Cash Flow (Quarterly) Benchmarks
Start Trial
Twist Bioscience Corp. -8.648M
Prime Medicine, Inc. -41.09M
Beam Therapeutics, Inc. -68.51M
Moderna, Inc. -563.00M
Tenax Therapeutics, Inc. -14.15M